QuidelOrtho (QDEL) FCF Margin Growth (1y) (2023 - 2024)

QuidelOrtho (QDEL) FCF Margin Growth (1y) (2023 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -80.00
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 473.00
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -192.00
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -431.00
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -1,716.00
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 2,833.00
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 2,811.00
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -125.00
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 QuidelOrtho 1.13 Bn 990.36 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2024 -2,392.00
Apr 2, 2023 -3,320.00